Progress seen in 'miracle' line of attack against genetic disorders

While we advise a strict moratorium on using the word "miracle" to describe brand new approaches to treating disease, researchers have certainly produced some interesting results from studies of ways to address codon signal errors that lead to the production of faulty proteins at play in genetic disorders such as cystic fibrosis and muscular dystrophy. The Telegraph reports today that scientists have figured out a potential way to rewrite the genetic code that leads to the diseases. "The ability to manipulate the production of a protein from a particular gene is the new miracle of modern medicine," the University of Rochester's Robert Bambara tells the British newspaper. Report

Suggested Articles

A Roche compound that was designed to treat rheumatoid arthritis could improve the heart's ability to repair itself, a Vanderbilt team found.

After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up…

In this week's EuroBiotech Report, Lundbeck inks $2 billion Alder buyout, Euro biotechs raise cash and blast rocks Russian smallpox lab.